MedPath

Comparison of Intravenous Ibuprofen And Intravenous Paracetamol In Reducing Migraine Headaches

Not Applicable
Conditions
Migraine.
Migraine without aura [common migraine]
Registration Number
IRCT2017050333787N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
400
Inclusion Criteria

Migraine disease; Age range of 16-60 years; Absence of other neurological disorders; Non-addiction.

Exclusion criteria: No neurological disorders; history of active peptic ulcer; pregnant women

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The pain. Timepoint: Time zero and two hours later. Method of measurement: Visual analogue scale (vas).
Secondary Outcome Measures
NameTimeMethod
Including stomach and intestinal ulcers and gastrointestinal bleeding. Timepoint: Two hours later. Method of measurement: Examination.
© Copyright 2025. All Rights Reserved by MedPath